Baffling the body into accepting transplants

Jan 21, 2009

An unexpected discovery made by a Sydney scientist has potential to alter the body's response to anything it perceives as not 'self', such as a tissue or organ transplant.

Stacey Walters, an immunology researcher at the Garvan Institute of Medical Research, has found that by greatly boosting the levels of the hormone BAFF in mice, it is possible to alter their immune systems so that they will accept tissue transplants without the need for any immunosuppression.

The findings have just been published in the Journal of Immunology.

Specifically, Stacey has found that mice genetically engineered to produce large amounts of BAFF (B cell activating factor), don't reject transplants.

She has shown that increased numbers of B cells (caused by boosted BAFF levels) in turn stimulate the production of T regulatory cells, which then control T cells, the body's killer cells.

The surprising thing about the results is that B cells, which make antibodies, were not known to have any role in the production of T regulatory cells. Nor would it have been thought possible for them to influence the body's response to a transplant, which has been considered a function of T cells only.

"In normal situations, something has to turn the immune system off once your body's fought an invader, such as a virus. It's the T regulatory cells that come in and say 'enough's enough'," Stacey explained.

Just to make sure it was the B cells that were provoking the changes, Stacey repeated her experiments on a mouse in which B cells were genetically knocked out, but high BAFF levels preserved. She found that when there are no B cells, normal allograft rejection occurs.

Stacey's results give us insight into previously unknown interrelationships between various classes of immune cells. Manipulating these relationships may offer a way of preserving organ grafts in the future without the need for toxic immunosuppressive drugs.

Source: Research Australia

Explore further: Clipping proteins that package genes may limit abnormal cell growth in tumors

add to favorites email to friend print save as pdf

Related Stories

Bacteria become 'genomic tape recorders'

Nov 13, 2014

MIT engineers have transformed the genome of the bacterium E. coli into a long-term storage device for memory. They envision that this stable, erasable, and easy-to-retrieve memory will be well suited for ap ...

What exactly is Google's 'cancer nanodetector'?

Nov 11, 2014

Last week, US tech giants Google made a splash in the media, announcing plans to develop new 'disease-detecting magnetic nanoparticles'. This was almost universally welcomed – after all, trying to detect ...

Researchers capture picture of microRNA in action

Oct 30, 2014

Biologists at The Scripps Research Institute (TSRI) have described the atomic-level workings of "microRNA" molecules, which control the expression of genes in all animals and plants.

Recommended for you

Organovo has 3D-printed liver tissue for drug testing

Nov 20, 2014

(Medical Xpress)—The commercial release of 3D printed liver tissue was announced earlier this week. Organovo is the company behind the release. The product is intended for use for preclinical drug discovery ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.